- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07929987
A Controlled Study on Fighting Against Anxiety in Older People Through an Educational Audio Programme. (ECLIPSE)
EXPLORATORY, PROSPECTIVE, MONO-CENTRIC, RANDOMISED, CONTROLLED, OPEN LABEL, STUDY EVALUATING BENEFITS OF A DIGITAL AUDIO PROGRAMME ON ANXIETY IN AGED CARE HOMES' RESIDENTS
In residential care homes for the elderly, safeguarding the mental and emotional health of aged people is a key factor in their well-being and the quality of care they receive. Among these disorders, anxiety plays a central role. Furthermore, in aged people, anxiety is frequently associated with other psychological and functional vulnerabilities, notably depression and sleep disorders, with which it frequently interacts. Taken together, these factors contribute to a cycle of emotional, cognitive and functional vulnerability that can impair the well-being of residents in care homes. In light of these challenges, non-pharmacological interventions (NPIs), which have the potential to reduce anxiety and depression and improve sleep, represent a particularly promising complementary approach and are attracting growing interest in the care of aged people living in care homes. The Simone Veil Gerontology Institute and Care Home of Cannes Hospital wishes to offer its residents a sound immersion programme as part of their standard care. The audio content is sourced from the SOMEO Life digital platform, an audio-guided application accessible via wireless headphones connected to a tablet or smartphone, allowing for individual or group use. This application offers pre-recorded sessions on relaxation, guided breathing and sophrology tailored to aged people living in care homes. In this context, this study aims to explore and evaluate, within a pragmatic and institutional framework, the benefits of an audio-guided sound immersion programme (SOMEO Life platform) on the current levels of anxiety among residents living in care homes. Depressive symptoms, sleep disorders and the use of anti-anxiety medication will also be assessed.
An exploratory, prospective, single-centre, randomised, controlled, open-label study evaluating the benefits of a digital audio programme on anxiety in elderly people in care homes is implemented. Forty patients will be recruited (twenty per groups) and followed-up during 3 months.
Primary objective is to determine whether adding an audio-guided sound immersion programme to standard care reduces the current level of anxiety (state anxiety) in patients in residential care homes for the elderly. Study endpoint is State-Trait Anxiety Inventory (STAI-Y), specifically the State Anxiety (Y-A) subscale.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Nathalie DOUX, Engineer
- Telefonnummer: +0033 0493697001
- E-post: n.doux@ch-cannes.fr
Studiesteder
-
-
Alpes-maritime
-
Cannes, Alpes-maritime, Frankrike, 06400
- Centre Hospitalier de Cannes Simone Veil
-
Ta kontakt med:
- Nathalie RONZIERE, Director
- Telefonnummer: 0033 0493697001
- E-post: direction@ch-cannes.fr
-
Hovedetterforsker:
- Charlotte PREVENT, Psychologist
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Residents who have been living in the care home for more than 2 months; · - A Mini Mental State Examination (MMSE) score of ≥ 20/30*, obtained in routine clinical practice within the 6 months prior to enrolment;
- Patients with sufficient French language understanding, as assessed by the investigators
- Patient's consent to participate in the study;
- For patients under guardianship, curatorship or judicial protection, consent from the legal representative.
- Social security scheme affiliation
Exclusion Criteria:
- Patients with hearing loss who do not wear a hearing aid or whose hearing impairment prevents them from making effective use of the audio equipment;
- Patients who, in the investigator's opinion, are unable to understand the objectives of the study or meet its criteria
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: control group: standard programme
"Standard" programme usually available for patients: organised on a group basis: cognitive stimulation workshops, leisure activities (outings, shows or films), inter-generational workshops (meetings with children), inter-care home workshops (meetings with other residents), soft gym, craft or creative workshops, relaxation and sophrology workshops, and choral |
"Standard" programme usually available for patients: organised on a group basis: cognitive stimulation workshops, leisure activities (outings, shows or films), inter-generational workshops (meetings with children), inter-care home workshops (meetings with other residents), soft gym, craft or creative workshops, relaxation and sophrology workshops, and choral
Andre navn:
|
|
Eksperimentell: experimental group: digital audio programme
|
"Standard" programme usually available for patients: organised on a group basis: cognitive stimulation workshops, leisure activities (outings, shows or films), inter-generational workshops (meetings with children), inter-care home workshops (meetings with other residents), soft gym, craft or creative workshops, relaxation and sophrology workshops, and choral
Andre navn:
A non-pharmaceutical, digital sound immersion solution designed to improve the wellbeing of elderly people in care homes. The app, developed by SOMEO Solutions, offers structured audio programmes incorporating verbal guidance and a soothing soundscape. The audio content can be accessed via a mobile device without the need to download an app, and the audio is played through wireless earphones or headphones connected to a transmitter The platform can be accessed via a QR code or a dedicated URL, without the need to download anything or create an account. Access is anonymous. The playback equipment can be standard headphones (or earphones) or a UHF wireless headphone kit - over-ear, closed-back, with individually adjustable volume, and compatible with hearing aids.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
State-Trait Anxiety Inventory (STAI-Y) A-section Scale
Tidsramme: From enrollment to the end of programme at 3months
|
State-Trait Anxiety Inventory (STAI-Y), in its State Anxiety (Y-A) section, measured at two timepoints:
|
From enrollment to the end of programme at 3months
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Charlotte PREVENT, Psychologist, Centre Hospitalier de Cannes Simone Veil
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2026-A01994-47
- CHC-PI/2026-03 (Annen identifikator: Centre Hospitalier de Cannes Simone Veil)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
data are own by CENTRE HOSPITALIER DE CANNES SIMONE VEIL, please contact sponsor for further information
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .